Replies to post #413043 on Amarin Corp Plc (AMRN)

[couldbebetter]

If AMRN decided to launch an authorized generic, I understand that those generic
drug purveyors who have many generic drugs in their stable have an advantage,
so I wonder if AMRN would be best off partnering for the US with one generic
seller. For Europe having the right acquirer or partner would be one that could
optimize the uptake of the drug in that part of the world. For China it would be
the same. The challenge is how to decide what jurisdictions to partner and
at the same time keep optionality open for a BO, if one is possible. It may be
that a partner may be given the option of acquiring AMRN for a certain period
of time. Alex Denner has absolute control over the entire BOD of AMRN which
is a unique position to be in.